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Mechanisms of Memory Enhancement 
 




The ongoing quest for memory enhancement is one that grows neces-
sary as the global population increasingly ages. The extraordinary pro-
gress that has been made in the past few decades elucidating the un-
derlying mechanisms of how long-term memories are formed has pro-
vided insight into how memories might also be enhanced. Capitalizing 
on this knowledge, it has been postulated that targeting many of the 
same mechanisms, including CREB activation, AMPA/ NMDA receptor 
trafficking, neuromodulation (e.g. via dopamine, adrenaline, cortisol or 
acetylcholine) and metabolic processes (e.g. via glucose and insulin) 
may all lead to the enhancement of memory. These and other mecha-
nisms and/or approaches have been tested via genetic or pharmaco-
logical methods in animal models, and several have been investigated 
in humans as well. In addition, a number of behavioral methods, in-
cluding exercise and reconsolidation, may also serve to strengthen and 
enhance memories. By capitalizing on this knowledge and continuing 
to investigate these promising avenues, memory enhancement may 
indeed be achieved in the future.  
[Keywords: memory enhancement, learning and memory, animal 
models] 
 
Sarah A. Stern, Cristina M. Alberini, Mechanisms of Memory Enhancement 
122 
Those who cannot remember the past are condemned to repeat it.  
                         George Santayana 
 
 
Memories1 are a fundamental part of our identity. As highlighted by the 
quote above, memories guide our behavior at every moment by re-
minding us of our past actions and their outcomes. For those individu-
als whose capacity to form memories is disrupted, life becomes in-
creasingly difficult and isolating. The cognitive dysfunction associated 
with many debilitating diseases, including Alzheimer’s disease (AD), 
diabetes, Parkinson’s disease (PD), and even in aging, demands effec-
tive therapies that can lead to recovery of memory functions or 
memory enhancement. 
One strategy that may lead to the identification of memory en-
hancers is to capitalize on the knowledge gained by the biological study 
of long-term memory formation and storage. In the last two decades, 
extraordinary progress has been made in the understanding of the cel-
lular and molecular mechanisms that are used for memory formation 
in several different species and types of learning. Results from these 
studies have left us with core knowledge about the role of conserved 
gene expression pathways, such as those regulated by the cAMP re-
sponse element-binding-CCAAT enhancer binding protein (CREB-
C/EBP) transcription factors (Alberini 2009). In parallel, cellular and 
electrophysiological investigations have led to the discovery of long-
term potentiation (LTP) and long-term depression (LTD) which provide 
cellular models for testing mechanisms of plasticity associated with 
memory formation (Bliss, Collingridge 1993). Disruption of these 
mechanisms has pointed to useful approaches and targets for the de-
velopment of therapies that attenuate obtrusive memories, such as 
 
1 Reprinted from Wiley Interdiscip Rev Syst Biol Med. 5(1), Stern S. A., Alberini C. 
M., Mechanisms of Memory Enhancement, 37–53 Copyright (2013); 
doi:10.1002/wsbm.1196. 
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those contributing to post-traumatic stress disorder (PTSD), phobias, 
and drug addiction (Ressler, Mayberg 2007). On the other hand, the 
identification of mechanisms that can amplify, enhance and/or 
strengthen synaptic plasticity represents potential therapeutic tools for 
enhancing adaptive memories and contrasting the onset and progres-
sion of disorders of cognitive functions. 
The focus of this Review is to provide an overview of the treat-
ments that have been reported to promote memory enhancement and, 
where known, their underlying mechanisms. Particular attention will be 
given to the description of the various stages of learning and memory 
storage that can be targeted for enhancement as well as the different 
forms of memories that can be enhanced. First, we will summarize the 
basic knowledge underlying learning and memory that is relevant for 
discussions pertaining to memory enhancement. We will then review 
mechanisms of memory enhancement found with various substances/ 
approaches, focusing on which types and stages of memory are en-
hanced in both animal models and human subjects. Given the vast lit-
erature on pharmacological compounds or approaches that modulate 
memory, it is not feasible to discuss every possible route to cogni-
tive/memory enhancement; however, it is our intent to summarize the 
major findings obtained with pharmacological, neuromodulatory and 
behavioral methods. Moreover, we do not provide a comprehensive 
knowledge of memory enhancement obtained in transgenic models, 
with a few exceptions that are pertinent to the topics of this review. 
We thus refer to excellent and exhaustive reviews for genetic ap-
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1. Defining Memory and Targeting Phases for Memory Enhance-
ment 
1.1 Stages of Memory Formation and Storage 
Since Ebbinghaus conducted his famous studies in memorizing non-
sense syllables (Ebbinghaus 1913), it has been universally recognized 
that memory consists of multiple stages, including acquisition/ encod-
ing, working memory/short-term memory, long-term memory/consol-
idation, memory retrieval, and reconsolidation (see Box A for detailed 
description of memory stages). Acquisition/Encoding is the initial stage 
of memory formation in which the subject learns something new (ie. 
acquires information). This process requires that the subject be atten-
tive, and that there be no retroactive or proactive interference that 
occlude learning of the current information. Working memory refers to 
the holding of information online in order to keep processing additional 
information, whereas short-term memory is the ability to hold the 
given information offline in mind for a given period. Short-term 
memory (STM) thus refers to memories that are held in mind for a 
relatively short period of time – seconds to minutes (ie. remembering 
a phone-number until you can write it down) (Cowan 2008). This differs 
from long-term memory, which can hold information for long periods 
of time, without a predefined limit on the quantity of information held. 
Long-term memories (LTM), in fact, can last for days, months, years, 
even a lifetime. The process that transforms the learned information 
into LTM is known as memory consolidation, the process that accom-
panies the transition from a labile memory to one that is stable and 
resistant to disruption. This transition requires a number of molecular, 
cellular and structural changes that occur over time, with some com-
pleting over hours or days and others extending over weeks, months 
or perhaps even years; once those events are completed, the memory 
is considered stable or consolidated (McGaugh 2000). If any of the 
phases underlying consolidation is disrupted, memory is lost. Finally, 
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retrieval is the process of recalling a memory. A challenge for studies 
aiming to identify the mechanisms of memory consolidation is the dif-
ficulty in discerning whether a memory deficit lies in the consolidation 
process (ie. the memory was never formed or was eliminated) or the 
retrieval process (ie. the memory is stored but cannot be retrieved, or 
recalled). Furthermore, it is likely that substances that enhance re-
trieval might be clinically beneficial, yet this stage of memory has re-
ceived little attention thus far. Importantly, both the number and mo-
dality of retrievals can influence memory consolidation and storage. In 
the 1960’s, and later again around the year 2000, it was shown that 
retrieval of a memory that has become resilient to the initial molecular 
interference initiates another round of consolidation as, in fact, this 
retrieved memory becomes again temporarily labile, and undergoes a 
re-stabilization process in order to be maintained (Nader, Einarsson 
2010). This re-stabilization is known as reconsolidation. The function 
of reconsolidation is still being debated, however, one compelling hy-
pothesis is that it facilitates memory strengthening, an intriguing out-
come which will be discussed in further detail below. Why is it im-
portant to differentiate these different stages of memory in the context 
of discovering memory enhancers? Cognitive dysfunction can result 
from impairments in one or more of these stages, and is it thus critical 
to identify stages can be selectively or better targeted for the most 
efficacious cognitive therapy. For example, a substance that enhances 
attention may increase the probability of the information being en-
coded successfully, and therefore may enhance the memory (Lynch, 
Palmer, Gall 2011). Additionally, a prominent symptom of the devas-
tating AD seems to be the inability to consolidate long-term memories, 
as a gradient of retrograde amnesia accompanies AD progression 
(Simard, Reekum 1999; Carlesimo, Oscar-Berman 1992). However, 
many AD patients also have attention deficits, which would in turn 
cause a problem with the initial encoding (Perry, Hodges 1999). This is 
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particularly true also for PD patients, where deficits in attention and 
executive control are the paramount cognitive impairments (Dubois, 
Pillon 1997). But even without the extremes of these devastating pa-
thologies, in healthy individuals – particularly with aging – a common 
complaint is not being able to “remember” well enough, which com-
monly refers to the inability to retrieve memories (Cansino 2009), 
though it is not entirely clear where the exact impairment in normal 
aging lies (Light 1991). Thus, in an experimental setting, it is important 
to consider which stage of memory a putative memory enhancer is 
affecting. This is relatively straightforward via pharmacological means, 
which can be administered at any time point, before or after training 
or retrieval. Genetic or molecular approaches represent other means 
to manipulate memories, and different behavioral tasks may be tested 
to get a sense of which stages are affected by the manipulation, for 
example working memory tasks vs. long-term memory tasks (See Box 
A for descriptions of common tasks used for these purposes). Undoubt-
edly, all behavioral, pharmacological and molecular approaches repre-
sent important levels of investigation that, in combination, can provide 
a better understanding of mechanisms of memory formation and en-
hancement. 
 
1.2. Types of Memories and Memory Systems 
Memories can be classified not only in a temporal manner, but also 
according to their type and function, as well as by which brain regions 
underlie their formation and processing (Squire 1992). The view that 
memories could be anatomically localized has been long disputed. A 
landmark discovery in this area was that of Brenda Milner who studied 
the memory deficits of a patient known as H.M. Due to severe epilepsy, 
H.M. underwent a bilateral medial temporal lobe resection and, while 
he emerged fully treated from the epilepsy, he developed profound 
memory deficits that were mostly restricted to the formation of long-
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term explicit memories. Studies conducted with H.M. and other pa-
tients with selective brain damage suggested that there are numerous 
memory types that can exist independently, but often interact (Corkin, 
Amaral, Gonzalez, Johnson 1997) (Figure 1). Explicit – or declarative 
– memories, which were disrupted in H.M., can be either semantic (re-
ferring to memories of facts or concepts ie. your date of birth) or epi-
sodic (referring to memories of events ie. your birthday party), and are 
subserved primarily by the medial temporal lobe, particularly by the 
hippocampus. Moreover, there are implicit types of memories, the 
memories of how to do things, which critically involve motor learning, 
such as skiing, playing piano, or riding a bicycle. One type of implicit 
memory is the memory formed as a consequence of simple associative 
learning; when the associations are emotional, (i.e. between a neutral 
stimulus and a stimulus with a valance, either aversive or rewarding), 
the learning relies primarily on the amygdala. When the associations 
produce reflexive skeletal responses, as in the case of delay eyeblink 
conditioning, the learning relies primarily on the cerebellum. A more 
gradual type of implicit learning that results in the formation of motor 
skills and habits relies primarily on the striatum. 
Importantly, these memory systems are not separated in nature, 
acting alone and on one type of memory, but rather, they coexist and 
often interact. For example, inhibitory avoidance and contextual fear 
conditioning memories that are commonly used in rodent memory 
studies (see Box A for description of behavioral tasks) involve multiple 
brain regions and multiple types of memories. In fact, these tasks re-
quire, for example, both an emotional, implicit component, mediated 
by the amygdala, and a contextual, explicit component mediated by 
the hippocampus. Similarly, by shifting certain parameters such as 
cueing specific arms or providing enriched contextual cues, the same 
radial arm maze with food reward (see Box A for a detailed description 
of task) can be used to train animals to visit specific arms by very 
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different strategies, mediated by either amygdala, hippocampus, or 
striatum (White, McDonald 2002). Thus, depending on task demands, 
various structures may be engaged to process what seems like identi-
cal information (ie. that a number of arms contain food) in different 
ways, producing different kinds of memories.  
For the purposes of developing memory enhancers, it is important 
to note that in cognitive impairments associated with AD or aging-re-
lated cognitive decline, the most vulnerable memories are those same 
memories that were lost in H.M. Implicit memories are very often 
spared, or at the very least, impaired at the last stages of the disease. 
Thus, there is an urgent need to identify therapies that target impair-
ments of hippocampal-dependent memories. However, as mentioned 
above, impairments associated with PD are often linked to working 
memory and executive control, and thus discovering mechanisms of 
enhancement for those disorders are equally important.  
Importantly, it is critical to keep in mind that there might be sev-
eral drawbacks with the use of cognitive enhancers; for example the 
effect could be non-selective enhancement, as a drug that enhances 
synaptic plasticity may result in the enhancement of both adaptive and 
maladaptive memories. Another drawback could be that memories are 
enhanced but become rigid and inflexible, or cognitive stimulants may 
lead to hyperactivation and seizure. Thus, while enhancement of in 
vitro synaptic plasticity and excitability is a useful tool for establishing 
physiological effects of various substances, it is always necessary to 
comprehensively investigate all possible effects using in vivo treat-
ments and behavioral as well as physiological measures, as they pro-
vide the most compelling evidence of which approaches will be most 
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2. Mechanisms of Memory Enhancement 
2. 1. Gene Expression: The CREB-C/EBP Pathway 
One of the first mechanisms identified as critical for long-term memory 
consolidation (both explicit and implicit) is the requirement for de novo 
protein and RNA synthesis (Davis, Squire 1984). Similar requirements 
have been found for long-term plasticity, including long-term facilita-
tion in Aplysia californica and a phase of LTP that lasts more than one 
hour, known as late-LTP (LLTP) (Alberini 2009), though not all late 
forms of LTP appear to share this requirement (Villers, Godaux, Ris 
2012). Many years of discussions have debated the functional effects 
of protein synthesis inhibitors used in many experiments, and we refer 
to this literature for questions, outcomes and debates (Alberini 2008; 
Sharma, Nargang, Dickson 2012). Regardless, the findings that in ad-
dition to pharmacological approaches molecular and genetic methods 
have provided evidence that transcription and translation are essential 
for memory, led to the subsequent discovery of important, evolution-
arily conserved pathways required for long-term memory formation: 
that regulated by the transcription factors CREB and C/EBP (Figure 2). 
CREB is activated by numerous signal transduction pathways impli-
cated in memory consolidation and enhancement, from growth factor 
stimulation of tyrosine kinase receptors coupled to the activation of Ras 
and extracellular signal-regulated kinase (ERK); to G-Protein Coupled 
Receptor (GPCR) activation coupled to activation of adenylyl cyclase, 
increase in cAMP, and activation of protein kinase A (PKA); to the ac-
tivation of stress pathways and glutamate release leading to release of 
intracellular calcium and relative downstream events. All of these path-
ways can lead to the activation of an activator form of CREB, CREB1. 
This activation in turn can lead to the transcriptional regulation of a 
number of target genes, including immediate early genes (IEG). Some 
IEGs are transcription factors, which regulate the expression of effector 
genes that are thought to participate in downstream synaptic changes 
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underlying synaptic plasticity. This is, for example, the case with the 
IEG/transcription factor C/EBPβ, a CREB-regulated target gene re-
quired for memory consolidation (Alberini 2009). 
Disrupting CREB1 results in memory deficits, while augmenting 
CREB1 activation results in memory enhancement. The first demon-
strations that CREB plays an essential role in both the disruption and 
enhancement of memory consolidation came from studies in inverte-
brates, namely Aplysia californica and Drosophila melanogaster. In Ap-
lysia, Bartsch et al. (Bartsch, Ghirardi, Skehel, Karl, Herder, Chen, Bai-
ley, Kandel 1995) reported that the disruption of ApCREB1, the Aplysia 
homolog of mouse CREB1 leads to an impairment in long-term facilita-
tion (a cellular model of long-term memory in Aplysia), and that the 
interference of a repressor form of CREB, ApCREB2, induces a longterm 
facilitation response from training protocols that would normally only 
produce shortterm facilitation. In parallel studies, Yin et al. (Yin, Del 
Vecchio, Zhou, Tully 1995)  using transgenic Drosophilae with a heat 
shock–inducible CREB repressor  soform (hs-dCREB2-b) showed that 
flies with the transgene on have impaired memory. Further studies in 
mice and rats extended these conclusions by showing that while the 
knockout or knockdown of CREB1 results in longterm memory impair-
ment, viral overexpression of CREB1 in amygdala and hippocampus 
enable LTM formation from massed training protocols of either cued-
fear conditioning or place learning, which normally produce only STM 
(Josselyn, Shi, Carlezon, Neve, Nestler, Davis 2001; Brightwell, Smith, 
Neve, Colombo 2007). In Aplysia, knockdown of C/EBP impairs long-
term memory, while overexpression of C/EBP leads to memory en-
hancement, similar to that produced by overexpression of CREB1, as 
short-term facilitation is converted to long-term facilitation (Alberini 
2012; Lee, Kim H., Kim K., Han 2001) Manipulations of C/EBP also lead 
to memory disruption or enhancement in rats (Alberini 2012) or mice, 
as hippocampal knockdown impairs memory, while forebrain 
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expression of a general dominant-negative inhibitor of the C/EBP/ATF 
family (EGFP/ AZIP), which presumably relieves their inhibition, results 
in enhanced spatial memory (Chen, Muzzio, Malleret, Bartsch, Verbit-
sky, Pavlidis, Yonan, Vronskaya, Grody, Cepeda et al. 2003). 
From the seminal studies that directly acted on CREB1 levels, 
many other findings followed and have identified memory-enhancing 
effects that correlate with increases in the activation of the CREB path-
way. A natural direction of these studies has been to target activators 
that are upstream of CREB, such as cAMP, PKA or mitogen-activated 
protein kinase (MAPK) (Xia, Huang, Guo, Southall, Cho, Inglese, Aus-
tin, Nirenberg 2008), though it is interesting to note that in certain 
cases in which neuronal excitability is altered, a decrease in cAMP sig-
nalling may actually be preferable (Wang, Gamo, Yang, Jin, Wang, Lau-
bach, Mazer, Lee, Arnsten 2011).  others have theorized that lifting the 
inhibition of CREB activation might be an effective route for memory 
enhancement. For example, in mice, releasing the inhibition provided 
by calcineurin, a Ca2+/calmodulindependent phosphatase which regu-
lates pCREB levels, also leads to memory enhancement, via CREB-de-
pendant mechanisms, of both short-term and long-term hippocampal-
dependent memories, without changing working memory (Malleret, 
Haditsch, Genoux, Jones, Bliss, Vanhoose, Weitlauf, Kandel, Winder, 
Mansuy 2001). In Aplysia, inhibition of calcineurin facilitates interme-
diate-term and LTM, but not STM (Sharma, Bagnall, Sutton, Carew 
2003). These studies have been extremely important in gaining an un-
derstanding of how memories can be enhanced in an experimental set-
ting by manipulation of CREB levels and/or activity, and imply that the 
activation of the CREB-dependent pathway might be an effective target 
for promoting and enhancing hippocampal-dependant LTMs. 
There have been a number of attempts to screen for drugs that 
via CREB activation could potentially be used as cognitive enhancers in 
humans. These screenings led to the identification of a number of 
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candidate drugs, including rolipram, which inhibits phosphodiesterate 
type 4 (PDE4), an enzyme that catalyzes hydrolysis of cAMP (Xia, 
Huang, Guo, Southall, Cho, Inglese, Austin, Nirenberg, 2008; Tully, 
Bourtchouladze, Scott, Tallman 2003). Additionally, CREB-C/EBP tar-
get genes may be valuable candidates for memory enhancement. One 
C/EBPβ-target gene upregulated after learning in the hippocampus and 
required for memory consolidation is the insulin-like growth factor 2 
(IGF-II or IGF-2). Administration of recombinant IGF-II immediately 
after learning or memory retrieval significantly enhances memory and 
prevents forgetting (Chen, Stern, Garcia-Osta, Saunier-Rebori, Pol-
lonini, Bambah-Mukku, Blitzer, Alberini 2011). The effect and action of 
IGF-2 as memory enhancer will be further discussed below. In general, 
it is important to recognize that, because CREB has important functions 
throughout the body and diverse effects throughout the brain, an ef-
fective treatment based on manipulating CREB or its target genes may 
require the development of strategies that enhance selectivity and 
specificity (Barco, Pittenger, Kandel 2003).  
 
2.2. Synaptic Remodeling 
Long-term memory formation is critically associated with synaptic re-
modeling, including the growth or pruning of synapses, as well as al-
tered synaptic efficacy (Lamprecht, LeDoux 2004). These changes oc-
cur through a number of local regulations, including mRNA translation, 
protein degradation, remodeling of cytoskeleton, and receptor traffick-
ing into and out of the synapse. 
One of the first transgenic manipulations that produced memory 
enhancement targeted receptor trafficking. In that study, Tang et al. 
(Tang, Shimizu, Dube, Rampon, Kerchner, Zhuo, Liu, Tsien 1999) 
overexpressed in the hippocampus of mice an N-Methyl-D-aspartic acid 
(NMDA) subunit, NR2B, that had previously been shown to be required 
for synaptic plasticity and LTM, and found that a number of memories 
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– namely, novel-object recognition, cued and contextual fear condi-
tioning, fear extinction, and Morriswater maze – were all significantly 
and persistently enhanced. Similarly, later studies showed that if the 
NR2B subunit was overexpressed in prefrontal cortex, working memory 
tasks such as the T-maze and a modified water maze were also en-
hanced (Cui, Jin, Zhang, Xu, Yang, Du, Zeng, Tsien, Yu, Cao, 2011). 
Although it is difficult to parse with a genetic manipulation what stage 
of the memory is being affected, pharmacological studies indicated that 
manipulations of NMDA receptors (NMDARs) can enhance both working 
memory and LTM-consolidation (Riedel, Platt, Micheau 2003) suggest-
ing that synaptic glutamate receptor expression and trafficking play a 
significant role in enhancing memory formation and maintenance. En-
hancement via NMDARs can be obtained both with agonists and low 
doses of antagonists (Danysz, Zajaczkowski, Parsons 1995), suggest-
ing that a tight regulation of NMDARs is required in order to facilitate 
memory processes. The mechanisms by which an enhanced NR2B re-
ceptor concentration at the synapses leads to memory enhancement is 
not yet understood. Some insights come from LTP and LTD studies, 
due to the fact that many similarities exist between the requirements 
for LTP induction and maintenance and LTM acquisition and consolida-
tion (Izquierdo 1994). One theory to explain the memory enhancement 
effects after increasing NR2B is that they may occur in part by the 
facilitation of LTP in these regions, whereas overexpression of an alter-
nate subunit, NR2A, facilitates LTD (Wang, Cui, Zeng, Kuang, Wang, 
Tsien, Cao 2009), perhaps because NR2B containing NMDARs are more 
calcium permeable than NR2A-containing NMDARs. In agreement with 
this model, partial agonists of NR2B improve memory and enhance LTP 
in aged rats that have LTP, but not LTD, deficits (Burgdorf, Zhang, 
Weiss, Matthews, Disterhoft, Stanton, Moskal 2011). 
The ability for NR2B overexpression to result in memory enhance-
ment may occur through the subsequent increased ability of NMDA 
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receptors to be activated due to their increased number. Indeed, par-
tial agonists of NMDARs such as D-cycloserine and D-serine have 
memory-enhancing effects. D-Cycloserine facilitates long-term fear 
memory consolidation in humans (Kalisch, Holt, Petrovic, De Martino, 
Klöppel, Büchel, Dolan 2009) and facilitates fear extinction in a rodent 
model of PTSD, perhaps through normalization of elevated levels of 
NMDAR subunit mRNA (Yamamoto, Morinobu, Fuchikami, Kurata, Ko-
zuru, Yamawaki 2008).  
Another critical receptor type that has been implicated in memory 
enhancement is the 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)pro-
panoic acid (AMPA) receptor. Though, like NMDARs, AMPARs respond 
to glutamate, they do not have a magnesium block and are therefore 
activated with less depolarization of the cell. Indeed, AMPARs them-
selves are required for NMDAR activation, as a synapse without AM-
PARs (known as silent synapses) will not be able to obtain sufficient 
depolarization to displace the magnesium block and allow calcium in-
flux (Rao, Finkbeiner 2007). In models of LTP, changes in AMPARS (ei-
ther through increases in the number of receptors, or changes in re-
ceptor effectiveness through phosphorylation) are thought to mediate 
the long-lasting changes that support LTP maintenance or persistence. 
For example, inactivation of the atypical protein kinase C isoform M 
Zeta (PKMzeta) in the amygdala and hippocampus leads to deficits in 
fear and object recognition memory in rats, which appears to be due 
to a decrease in post-synaptic GluR2-containing AMPARs (Migues, 
Hardt, Wu, Gamache, Sacktor, Wang, Nader 2010). Overexpression of 
PKMzeta in insular cortex leads to enhancement of conditioned taste 
aversion memory in rats, and the underlying mechanisms are under 
investigation (Shema, Haramati, Ron, Hazvi, Chen, Sacktor, Dudai 
2011). Similarly, long-term memory correlates with an increase in syn-
aptic AMPA receptors, which are known in vitro to be trafficked via the 
endosomal system (Ehlers 2000). Synthetic compounds, known as 
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Ampakines, which allow glutamate to have a prolonged effect on AM-
PARs, have been found to strengthen memory retention on a number 
of tasks and in a number of different species (Lynch 2006). These com-
pounds have the advantage of passing the blood-brain barrier and of 
being selective for the central nervous system (CNS).  
A number of compounds known to enhance memory are also 
known to increase NMDAR/ AMPAR levels (Slutsky, Abumaria, Wu, 
Huang, Zhang, Li, Zhao X, Govindarajan, Zhao M-G, Zhuo, et al. 2010; 
Hu, Real, Takamiya, Kang, Ledoux, Huganir, Malinow 2007; Krugers, 
Hoogenraad, Groc 2010). However, there is still little known about 
which subunits are increased at different stages of memory. One mech-
anism of action could be that NMDARs activate CREB and set in motion 
the gene expression changes discussed above. These changes would 
then lead to morphological modifications at the synapse, including 
growth of new spines and increased AMPAR insertion (Figure 3). It is 
possible that these synaptic changes may represent the endpoint of 
many memory enhancers. Hence targeting receptor expression may be 
a general approach to achieve memory enhancement.  
One regulatory protein that seems to be linked to receptor traf-
ficking regulation and is induced by learning and required for memory 
consolidation is the immediate early gene Arc. A number of studies 
have linked in particular Arc to NMDA/AMPA receptor trafficking (Rao, 
Finkbeiner 2007) and memory enhancement (Chen, Stern, Garcia-
Osta, Saunier-Rebori, Pollonini, Bambah-Mukku, Blitzer, Alberini 2011; 
McReynolds, Donowho, Abdi, McGaugh, Roozendaal, McIntyre 2010). 
In vitro studies have shown a role for Arc in removal of Glur1 from 
synapses, and recent works shows that Arc may in fact be tagged to 
inactive synapses to depress them during memory formation (Okuno, 
Akashi, Ishii, Yagishita-Kyo, Suzuki, Nonaka, Kawashima, Fujii, Take-
moto-Kimura, Abe et al. 2012). Synaptic remodeling leading to 
memory enhancement does not only refer to changes in synaptic 
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receptors. More global, morphological changes of the synaptic archi-
tecture have also been shown to correlate with memory enhancement. 
Rho-GTP-ases, which lead to remodeling of the actin cytoskeleton, en-
hance memory when rendered constitutively active by Cytotoxic ne-
crotizing factor 1 (CNF1), a protein toxin from Escherichia coli (Diana, 
Valentini, Travaglione, Falzano, Pieri, Zona, Meschini, Fabbri, Fiorentini 
2007). Similarly, cell adhesion molecules such as neural cell adhesion 
molecule (NCAM), which are involved in the remodeling of neural cir-
cuits, have been successfully targeted for memory enhancement in ro-
dents, via a mimetic peptide that interacts with the fibroblast growth 
factor receptor (FGFR) (Cambon, Hansen, Venero, Herrero, Skibo, Be-
rezin, Bock, Sandi 2004). There are also suggestions that changes in 
spine shape and size may correlate with memory formation, as LTP is 
associated with increases in stable, mushroom-shaped spines (Bourne, 
Harris 2007), but direct causative knowledge about how changes in 
spine morphology relate to memory in general, and specifically to 
memory enhancement, are still lacking.  
 
2.3. Neuromodulation 
Neuromodulators, which alter cellular and synaptic properties via wide-
spread projections (Kupfermann 1979) have a well-known role in 
memory function and many modulation pathways have been targeted 
for memory enhancement (Floresco 2011). 
One neuromodulator with a well-known effect on cognition is do-
pamine. Dopamine action is particularly evident in patients who suffer 
from PD, which involves a loss of dopaminergic neurons and conse-
quently severe motor deficits. The loss of dopamine is also accompa-
nied by a noticeable cognitive impairment in many patients, who are 
diagnosed with dementia as the disease progresses (Mckeith, Burn 
2000). However, even in PD patients without dementia, many cognitive 
domains appear to be impaired during neuropsychological 
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examination. In contrast with many other diseases of cognitive impair-
ment, PD is specifically accompanied by deficits in tasks associated 
with prefrontal cortex, including executive function and planning, ra-
ther than with memory consolidation impairments (Dubois, Pillon 
1997). Dopamine is thus widely thought to be extremely important for 
working memory tasks relying on the prefrontal cortex (PFC), and low 
levels of dopamine receptor D1 (DRD1 or D1) antagonists enhance 
working memory as revealed by an increase in neuronal activity during 
a delay period of a delayed-non-match-to-sample task, whereas high 
levels of antagonists and agonists both impair that activity (Williams, 
Goldman-Rakic 1995). Hence, there is an inverted-U curve effect of 
dopamine on working memory. However, the effects of dopamine on 
working memory may be restricted to improvement of conditions com-
promised in dopamine function, as the same treatments in young ani-
mals do not show memory enhancement that is seen in aged animals 
(Castner, Goldman-Rakic 2004). The effects of dopamine alterations 
on LTM have been given less attention. An early study showed that 
dopamine itself given i.c.v. to mice after training enhanced step-
through IA at 24h (Haycock, Van Buskirk, Ryan, McGaugh 1977), and 
recently, the D1 agonist SKF38393 given i.p. post-training was shown 
to enhance 24h and 72h memory of novel object recognition in rats (de 
Lima, Presti-Torres, Dornelles, Scalco, Roesler, Garcia, Schröder 
2011). Many of the behavioral results are complemented by electro-
physiological data showing that AMPA and NMDA currents are en-
hanced by the injection of a D1/D5 agonist in the hippocampus (Yang 
2000). 
It has long been known that emotional events are better remem-
bered than non-emotional events. Therefore, other neuromodulators 
that are particularly important for memory are the stress hormones 
corticosteroids and adrenaline, which are released during arousing ex-
periences. Corticosteroids can activate two receptors – glucocorticoid 
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(GR) and mineralocorticoid (MR). While MRs have a very high affinity 
for corticoids and are therefore tonically activated, GRs have a much 
lower affinity and are therefore preferentially activated in conditions of 
high stress. Manipulations of both receptors have effects of memory, 
but the behavioural effects of GR have been better characterized (Kru-
gers, Hoogenraad, Groc 2010). Thus, when cortisol (in humans) or cor-
ticosterone (in rodents) is released in concert with a stressful experi-
ence, memory is better recalled at later times (McGaugh, Roozendaal 
2002). The enhancing effect of cortisol administration can be obtained 
via behavioral methods of inducing stress as well, a this is thought to 
be a key mechanism regulating intrusive memories that occur with 
post-traumatic stress disorder (PTSD) (Yehuda 2002). However, it is 
also known that very intense or prolonged stress may cause memory 
impairments, as may be the case with intense physical exertion such 
as occurs with marathon runners (Eich, Metcalfe 2009). Experimen-
tally, this effect is known as the inverted-U effect of stress on perfor-
mance, and is seen in animal models as well. Moderate to high stress 
produce a robust memory in rodents, whereas extremely high stress 
results in low memory retention. Many studies conclude, however, that 
glucocorticoids can only enhance memories that inherently involve 
emotional arousal. Animals tested in a novel context for object recog-
nition show memory enhancement via corticosterone administration, 
whereas animals that underwent habituation to the context prior to 
training did not show enhancement with corticosterone (Roozendaal, 
Okuda, Van der Zee, McGaugh 2006). Likewise, administration of nor-
adrenaline after training enhances memory retention (Gold, Ruskirk 
1976) which likely occurs through the activation of beta-adrenergic re-
ceptors, subsequent activation of adenylyl cyclase, PKA and Ca2+/cal-
modulin-dependent protein kinases II (CAMKII). Thus, specific agonists 
of β-adrenergic receptors enhance memory, similarly to what occurs 
via increased arousal during encoding. Noradrenaline is produced 
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primarily in the locus coeruleus and adrenal medulla and many enhanc-
ing effects of other modulators, such as glucocorticoids, are critically 
regulated by the activity of noradrenaline in the amygdala, as sug-
gested by classical studies of Roozendaal et al. showing that a β-adre-
nergic receptor antagonist infused into the amygdala blocks memory 
enhancement produced by glucocorticoids infused into the hippocam-
pus (Roozendaal, Nguyen, Power, Mcgaugh 1999). 
In line with all these findings, a number of stimulant drugs that 
work on inhibiting monoamine reuptake, including amphetamines, 
methylpehidate (Ritalin®) and modafinil (Provigil®), have been found 
to improve cognitive function in patients with attention-deficithyperac-
tive-disorder (ADHD), and there have been reports of improved func-
tion in healthy subjects as well. Recently, methylphenidate was tested 
on human subjects who learned a list of words; immediate recall did 
not differ, but delayed recall, 1 day to 1 week later, showed improve-
ment at two doses (Linssen, Vuurman, Sambeth, Riedel 2011). 
Though prior studies did not find the same effect, the authors note 
that this may be due to shorter word lists that were used which may 
have produced a ceiling effect. Regardless, methylphenidate is well 
known to have pronounced effects on spatial working memory and sus-
tained attention (Advokat 2010). The same is generally thought to be 
true of modafinil, which is traditionally prescribed for narcolepsy. Some 
studies indicate that positive effect on cognition may be due to in-
creased arousal and attention rather than enhancement of LTM or con-
solidation processes (Lynch, Palmer, Gall 2011). Thus, modafinil may 
be effective in treating specific aspects of cognitive dysfunctions that 
target attention rather than memory. 
Acetylcholine is perhaps one of the most well-studied neuromod-
ulators in the context of hippocampal-dependant memory, and the ac-
etylcholine theory of memory enhancement has been studied for many 
years. Acetylcholine is required for memory formation, as observed by 
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lesion studies as well as pharmacological inhibition of acetycholine nic-
otinic and muscarinic receptors. Focusing on memory enhancement, a 
number of agonists of these receptors have been targeted with varying 
results (Deiana, Platt, Riedel 2011). Moreover, observations in labora-
tory mice that inhibiting acetylcholine uptake could enhance memory 
led to drugs designed to inhibit the enzyme responsible for degrading 
acetylcholine, acetycholinesterase. These drugs, namely donepezil 
(Aricept®) are now the only available treatment for mild- to moderate- 
AD. Meta-analyses of the clinical trials studies indicate that although 
there are benefits of these drugs, the magnitude of their benefit is lim-
ited because they offer symptom relief without modifying the disease 
(Birks 2009). Moreover, the beneficial effects are possibly restricted to 
attention processes rather than enhancing consolidation mechanisms, 
and may in fact impair memory consolidation by maintaining consist-
ently high levels of cholinergic activity (Deiana, Platt, Riedel 2011; 
Prickaerts, Sik, van der Staay, de Vente, Blokland, 2005). 
 
2.4. Endogenous Substances 
The effects on memory enhancement discussed above are mainly the 
results of pharmacological manipulations with synthetic compounds, 
especially for those used in clinical studies, as is the case with Am-
pakines, D-Cylcoserine, and Donepezil. However, a number of endog-
enous substances, primarily those that are key players in metabolic 
processes (ie. glucose and insulin), have been known to have a direct 
memory enhancing effect for quite some time. Early studies showing 
that recently fed subjects performed better than those who had not 
eaten for some time piqued a long-lasting interest in whether glucose 
administration can enhance memory functions (Lapp 1981). Subse-
quently, a wealth of studies examined glucose-mediated memory en-
hancement, in both animal models as well as humans due to the rela-
tive ease and safety of glucose administration. 
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Though there have been contrasting findings (Azari 1991; Foster, 
Lidder, Sünram 1998), the majority report that in healthy, young adult 
rodents and humans memory is enhanced by glucose given pre- or 
post- training, indicating that glucose may be able to facilitate both 
encoding and memory consolidation, thought in healthy individuals this 
may be true only when task demands are high(Smith, Riby, Eekelen, 
Foster 2011). Importantly, in humans, the vast majority of studies use 
participants that have fasted for at least 2 hours to overnight before 
training, indicating that many of the effects seen might actually be in-
dicating that glucose deprivation is deleterious, rather than enhance-
ment by glucose itself. The enhancing effects of glucose was mainly 
found on declarative, hippocampal-dependant memories tested at rel-
atively early time points (up to 24h) after training (Gold, Vogt, Hall 
1986). The effects of glucose administration on cognitively-impaired 
individuals vary, revealing that individuals with very mild problems 
may have a longer-lasting enhancement by glucose, but those who 
have already a progressed disease do not show a sustained memory 
enhancement (Gold, Vogt, Hall 1986). 
The mechanisms by which glucose enhances memories are not yet 
entirely understood. A number of studies indicate that the effect may 
be due to insulin, whose receptors are highly enriched in the hippo-
campus. In itself, insulin has been shown to enhance hippocampalde-
pendent memories in both rats and humans. However, in rats, insulin-
mediated memory enhancement has not been tested past 24h (McNay, 
Ong, McCrimmon, Cresswell, Bogan, Sherwin 2010) and may not per-
sist up to 1 week after inhibitory avoidance training (Stern and Alberini, 
unpublished data). Recent studies suggest that insulin may provide 
memory enhancement also in humans (Benedict, Hallschmid, Hatke, 
Schultes, Fehm, Born, Kern 2004) and several indicate that the en-
hancing effects of glucose may be due entirely to glucose-stimulated 
increases in insulin levels (Craft, Asthana, Newcomer, Wilkinson, 
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Matos, Baker, Cherrier, Lofgreen, Latendresse, Petrova, et al. 1999). 
In AD patients, hyperinsulinemia improves performance independent 
of glucose levels, but hyperglycemia, while maintaining insulin levels 
at baseline, does not provide the same benefit. Intranasal insulin ad-
ministration has begun to be tested in patients with mild cognitive im-
pairment and mild-to-moderate AD. In a double-blind study of patients 
given insulin over 4 months, improvement was seen in a number of 
measures tested at months 2 and 4 of treatment, as well as two months 
after treatment was discontinued. The most significant improvement 
was seen on delayed score recall test (measured with a delay of 20 
minutes), but improvements were also seen in a general tests of cog-
nitive ability and partnership scores, a measure of assessment for care-
takers of AD patients (Craft, Baker, Montine, Minoshima, Watson, Clax-
ton, Arbuckle, Callaghan, Tsai, Plymate, et al. 2012). These results are 
very promising, and it would be important if follow-up studies examine 
memory over longer delays. 
In rats, in contrast to glucose and insulin which showed transient 
effects, a single administration of IGF-II was recently found in our lab 
to enhance hippocampal-dependant memory for at least three weeks 
when administered post-training (Chen, Stern, Garcia-Osta, Saunier-
Rebori, Pollonini, Bambah-Mukku, Blitzer, Alberini 2011). Furthermore, 
IGF-II injected into rat hippocampus was found to enhance extinction 
in mice (Alberini, Chen 2012; Agis-Balboa, Arcos-Diaz, Wittnam, Go-
vindarajan, Blom, Burkhardt, Haladyniak, Agbemenyah, Zovoilis, Sa-
linas-Riester, et al. 2011). IGF-II is part of the insulin-like growth fac-
tor system, which also includes insulin and insulin-like growth factor I 
(IGF1 or IGF-I). Interestingly, IGF-I does not seem to have any 
memory enhancement effect on the tested memories. The memory en-
hancing effect of IGF-II requires the IGF-II, but not IGF-I, receptor. 
This is interesting because unlike IGF-I and insulin receptors, IGF-IIR, 
which is identical to the cation-independent mannose-6-phosphate 
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receptor, is not a tyrosine-kinase receptor, but a receptor that targets 
proteins to endosomes and lysosomal degradation processes (Roth 
1988). Very little is known about what downstream mechanisms cause 
this persistent memory enhancement, but due to the receptor require-
ment and the different temporal dynamics, it seems likely to hypothe-
size that it uses mechanisms distinct from those of insulin or glucose. 
Interestingly, IGF-II-mediated memory enhancement correlates with 
increases in synaptic GluA1 receptor at 30 minutes after training, indi-
cating that endogenous targeting of AMPARs may be very effective in 
promoting memory enhancement. IGF-II may also have an effect on 
the cholinergic system. In hippocampal neurons, IGF-II potentiates ac-
etylcholine release (Hawkes, Jhamandas, Harris, Fu, MacDonald, Kar 
2006); therefore, it is possible that an endogenous effect of IGF-II is 
to potentiate acetylcholine release and action, in addition to regulating 
other mechanisms. Though very little is known about the role of IGFII 
in cognitive functions, the ability for IGF-II to pass the blood-brain-
barrier (Reinhardt, Bondy 1994) makes it a particularly exciting com-
pound for both preclinical and clinical studies.  
Other growth factors, for example brain-derived neurotrophic fac-
tor (BDNF), also regulate memory retention. A number of studies have 
shown increased BDNF mRNA or protein levels following memory en-
hancement treatments (Slutsky, Abumaria, Wu, Huang, Zhang, Li, 
Zhao, Govindarajan, Zhao, Zhuo 2010; Lynch 2002; van Praag 2009). 
However, there seem to be no current evidence that BDNF itself can 
enhance memory in a non-diseased animal when given close to the 
time of training, as is the case with IGF-II. However, BDNF appears to 
increase memory persistence. For example, BDNF injected into the dor-
sal rat hippocampus 12 hours after an IA training with a low footshock, 
which produces a memory that would normally be forgotten by 7 days, 
leads to memory persistence (Bekinschtein, Cammarota, Igaz, 
Bevilaqua, Izquierdo, Medina 1997). In disease models, BDNF may 
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reverse memory deficits, making it an attractive candidate for selective 
enhancement of failing memories.  
 
2.5. Behavioral Methods 
In addition to pharmacological approaches, there are a number of be-
havioral manipulations that have been found to be effective in promot-
ing memory enhancement. First, repetition has long been known to 
enhance memory performance, and it has been consistently shown that 
repeated training trials and/or learning events are associated with bet-
ter memory (Pinsker, Hening, Carew, Kandel 1973). This method is 
one that is employed during everyday learning, and is also known to 
have benefits for cognitive disorders such as dementia. 
Similarly, memory can be enhanced by targeting retrieval-induced 
reconsolidation, which occurs through repeated retrieval sessions. 
When a memory is retrieved, it can again return to a labile state and 
can undergo reconsolidation (Alberini, Milekic, Tronel 2006). It has 
been suggested that a function of reconsolidation is to increase 
memory strength (Sara 2000). Recently in our laboratory it was found 
that, in IA, multiple memory reactivation by brief (10 sec) exposures 
to the context results in memory enhancement in rats through recon-
solidation, whereas multiple retrievals consisting of a full testing ses-
sion can result in fear extinction (Inda, Muravieva, Alberini 2011). No-
tably memory changes over time, and in order to attain a memory 
enhancing effect, retrievals must occur within a relatively short time-
span after training. Indeed the same multiple 10 second retrievals 
which had lead to enhancement if given during the first week after 
training, result in fear-extinction when given 4 weeks post-training, 
indicating that memory strengthening is a function of the age/ stage of 
the memory and that likewise, memory storage is dynamic and 
changes over time. However, there is currently little knowledge about 
the mechanisms by which these changes occur, or whether the 
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behavioral effect based on reconsolidation would be useful in aging 
and/or AD. 
Interestingly, the reconsolidation process does not promote 
memory enhancement by behavioral repetitions only. Memory en-
hancement can be in fact promoted via pharmacological manipulations 
given in concert with reconsolidation. Thus, injections of nicotine, β-
adrenergic receptor agonists, PKA activators, phosphodiesterase type 
5 inhibitors, angiotensin and IGF-II all enhance memory when injected 
after retrieval (Alberini, Chen 2012; Dębiec, Bush, LeDoux 2011; Tian, 
Huang, Li, Li, Zhou, Deng, Yang 2011). This suggests that memories 
can be enhanced even after they are consolidated, and indicates po-
tential new directions for developing treatments for cognitive disorders 
that targets in addition to deficits of encoding/consolidation also defi-
cits of already formed memories. 
Another behavioral approach that has been recently found to be 
effective in enhancing memories is physical exercise. Numerous stud-
ies over the past two decades in rodents have shown conclusively that 
exercise can improve memory in a number of tasks, including the spa-
tial task water maze, the fear task IA and the non-aversive task novel 
object recognition. This effect may be more pronounced in aged rats, 
and has numerous possible underlying mechanisms, including increase 
of the neurotrophin brain derived neurotrophin factor (BDNF), neuro-
genesis, IGF-I, glucocorticoids, and CAMKII activation (van Praag 
2009), suggesting once again that  echanisms involved in memory con-
solidation may be the best targets to achieve memory enhancement or 
prevent memory decay. Though it is generally accepted that exercise 
is beneficial in regards to general health, extended lifespan and aging, 
the extent and type of exercise needed in humans to attain a benefit 
specifically for memory enhancement is not yet mechanistically well 
understood, and excessive forms of exercise may actually be deleteri-
ous for declarative, hippocampal-dependent memories by causing 
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extreme stress, as noted above (Eich, Metcalfe 2009). Behavioral 
methods for enhancing memory are an exciting avenue of research, 
and may be extremely useful in clinical practice with more basic 
knowledge of how best to implement their practice, as well as whether 
they can be even further augmented through pharmacological means, 
as with reconsolidation-mediated enhancement. 
 
3. Sidebar title Behavioral Tasks in Rodents 
Pavlovian Fear Conditioning pairs an unconditioned stimulus (US), 
which elicits an automatic response (ie. a mild footshock elicits fear 
behaviors), with a conditioned stimulus (CS), which has no inherent 
valance but subsequently elicits the same behavior as the US (ie. a 
tone). Common versions of this task are auditory fear conditioning 
(AFC) and contextual fear conditioning (CFC), which pairs a tone and 
context, respectively, with a footshock. Memory is measured as the % 
time spent freezing during the test.  
Inhibitory Avoidance (IA) trains the animal to avoid the dark side 
of a two-chamber apparatus in which it was previously given a foot-
shock. During testing, memory is measured as the latency to enter the 
dark compartment.  
Extinction extends fear-based tasks in which the animal learns 
through subsequent presentations of the CS without the US that the 
previously fearful CS is now safe.  
Morris Water Maze trains animals to find an escape platform in a 
circular water maze. Memory during probe trials can be measured as 
the percentage of time spent in the correct quadrant or latency to find 
the platform.  
Novel Object Recognition (nOR) exploits rodent’s natural tendency 
to explore novel objects. Animals are trained with two identical objects, 
and during testing, memory is measured as the % time spent with the 
novel object. This task can also be modified to ask if animals remember 
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“where” versus “what” by moving one of the objects rather than re-
placing it with a new object (known as Object Placement).  
Radial Arm Maze trains animals to go to specific arms of an 8-arm 
maze to obtain a food reward. Arms may be cued or contextual cues in 




There are a number of promising avenues in the field of memory en-
hancement, some of which have been discussed in this Review. There 
is now a significant amount of information regarding molecular path-
ways that are likely to be among the most important targets for en-
hancing memories; however, much remains to be understood to trans-
late this knowledge into clinical trials. For example, most studies in 
animal models examine effects in males, but a number of studies have 
shown that there may indeed be sex differences (Leuner, Shors 2004; 
Mizuno, Giese 2010). This is an important outstanding question that 
needs to be addressed further. 
The strategies that have promoted memory enhancement in ani-
mal models thus far have primarily relied on mechanisms of memory 
consolidation, such as the CREB-C/EBP pathway and receptor traffick-
ing, which have been mainly studies in aversive or spatial memory 
tasks. These are mechanisms that are thought to be important for en-
hancing hippocampal-dependent memories and contrasting cognitive 
decline in aging and AD. Other studies have focused on the effects of 
treatments to enhance working memories, such as targeting dopamine 
neuromodulation that will be useful for diseases such as PD. 
Importantly, cognitive enhancement therapies may be useful in 
some situations, but not others. Some may be beneficial in enhancing 
memory in healthy adults and during normal aging. Others may com-
pensate for disease-related changes, or may instead restore those 
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changes to their original, healthy state. Thus, all potential enhancers 
must be tested for their mechanisms of action. 
One important aspect that remains to be deeply investigated is 
the question of specificity and flexibility – not all possible memories 
require or benefit from enhancement, and it is unclear if/when memory 
enhancement interferes with new learning and the consolidation of new 
memories. To date, very little attention in animal studies has been 
given to enhancement of memory retrieval and to enhancement of re-
mote memories, both of which may be important areas of study with 
very important translational potential. 
The study of memory enhancement holds the potential for great 
progress in the treatment of numerous diseases of the mind, and for 
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Box A. Behavioral Tasks in Rodents 
Pavlovian Fear Conditioning – An task pairing an unconditioned stimu-
lus (US), which elicits an automatic response (ie. a mild footshock that 
elicits fear behaviors), with a conditioned stimulus (CS), which has no 
inherent valance but subsequently elicits the same behavior as the US 
(such as a tone). Two common versions of this task are auditory fear 
conditioning (AFC) and contextual fear conditioning (CFC), which pairs 
a tone and context, respectively, with a footshock. Memory is meas-
ured as the % time spent freezing during the test. 
Inhibitory Avoidance (IA) – A one-trial task in which the animal learns 
to avoid the dark side two-chamber apparatus in which it was previ-
ously given a footshock,. During testing, memory is measured as the 
mean latency to enter the dark compartment. Extinction – An exten-
sion of fear based tasks in which the animal learns through subsequent 
presentations of the CS without the US that the previously fearful CS 
is now safe. 
Morris Water Maze – A task of hippocampal-dependant memory in 
which animals are trained to find an escape platform in a circular water 
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maze. Memory during probe trials can be measured as the percentage 
of time spent in the correct quadrant. 
Novel Object Recognition (nOR) – A non-aversive task which exploits 
rodent’s natural tendency to explore novel objects. Animals are trained 
with two identical objects, and during testing, memory is measured as 
the % time spent with the novel object. This task can also be modified 
to ask if animals remember “where” versus “what” by moving one of 







































Figure 1. Multiple memory systems as targets of memory enhancement 
Modified from Squire 1992 
Memory consists of multiple stages and types. A number of different stages (in blue) 
are involved in acquiring, storing and retrieving a memory. A number of cognitive 
disorders (in red) have symptoms that are associated with deficits in specific stages, 
while others may have deficits that are more general or unclear in nature (such as 
those in cognitive decline over aging). Long-term memory can be subdivided into a 
number of different types which rely on different brain regions (in purple). Impair-
ments of these different memories are also associated with different disorders. Puta-
tive memory enhancers may be associated with the the improvement of a specific 
stage or memory type, which will therefore affect the clinical population that will 
receive therapeutic benefit. WM: working memory; STM: short-term memory; LTM: 
long-term memory. Copyright © [1992] by the American Psychological Association. 
Adapted with permission. Squire, L. R. (1992). Memory and the hippocampus: A 
synthesis from findings with rats, monkeys, and humans. Psychological Review, 
99(2), 195–231. doi:10.1037/0033-295X.99.2.195 The use of APA information does 
not imply endorsement by APA. 
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Figure 2. Schematic representation of the CREB-C/EBP pathway targeted for memory 
enhancement 
Taken from: Alberini, Chen, 2012. A number of intracellular signal transduction pathways are activated 
upon learning by diverse stimuli, such as stress, neurotransmitters, growth factors and membrane depo-
larization, and lead to activation of the CREB-C/EBP pathway. Growth factors bind to and signal via dimer-
ized receptor tyrosine kinase (RTK), which induces activation of both the Ras/Raf/mitogen-activated pro-
tein kinase (MAPK)/MAP kinase kinase (MEK) pathway and the phosphatidylinositol 3-kinase (PI3K)-de-
pendent pathway. Activation of these pathways recruit additional protein kinases, including p90 ribosomal 
S6 kinase (RSK2) and mitogen- and stress-activated protein kinase (MSK) for the MAPK-dependent path-
way and Akt and p70S6 kinase(p70S6K) for the PI3K-dependent pathway to catalyze phosphorylation of 
CREB (pCREB) in its Ser-133 residue, which is an important step for its activation. Another route of CREB 
phosphorylation is through neurotransmitters binding to their receptors, through which they can couple 
cAMP by regulating adenylyl cyclase (AC) activity. cAMP recruits protein kinase A (PKA) as the main kinase 
for CREB phosphorylation. Phosphodiesterase (PDE) can catalyze the hydrolysis of cAMP and inhibit its 
signaling. Additionally, increases in intracellular Ca2+ influx through voltage- or ligandgated cation chan-
nels, such as voltage-sensitive calcium channels (VSCCs) or NMDA receptors (NMDARs), can also lead to 
CREB phosphorylation via different calciumdependent protein kinases. Once phosphorylated, CREB recruits 
its transcription coactivator CREB-binding protein (CBP) to promote transcription of CREB-target genes, 
such as the immediate early gene, C/EBP. C/EBP, in turn, regulates a number of late-response genes, for 
example, IGF-II. Targeting any of these upstream pathways in a manner that leads to increased CREB or 
C/EBP activation, or targeting CREB-C/EBP target genes (as in the case of IGF-II), may in turn lead to 
long-term memory enhancement.  
Reprinted from Trends in Neuroscience 35(5), Alberini CM, Chen DY. Memory Enhancement: consolidation, 












Figure 3. Synaptic remodeling that occurs with learning 
Taken from Rao and Finkbeiner 2007. 
Presynaptic activity that occurs with learning or stimulation leads to a release of 
glutamate onto NMDA and AMPA receptors, which depolarizes the membrane. This 
leads to a number of intracellular changes, including activation of transcription fac-
tors, and translation of their downstream targets (Left Panel). These in turn lead to 
growth initiation, including protein synthesis (for example, of Arc), which then lead 
to the addition (Middle Panel) and stabilization (Right Panel) of new spines through 
insertion of new NMDA and AMPA receptors. Targeting synaptic remodeling mecha-
nisms to increase receptor insertion may be an effective route for memory enhance-
ment. Reprinted from Trends in Neuroscience 30(6), Rao VR, Finkbeiner S. NMDA 



























Critical Hermeneutics, special 2 (2020) 
165 
Table 1 
Summary of memory enhancement effects presented in the present review, including species and tasks 
tested. 
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